Founded in early 2021, Altos Labs already has offices in Silicon Valley, San Diego, the United Kingdom and Japan, reminiscent of Calico Labs, a start-up company dedicated to longevity research founded by Larry Page in 2013.
Mexico City (apro).- Altos Labs is a Silicon Valley startup that studies cell regeneration and methods of rejuvenating animals and humans.
Although the ultimate goal is to find the source of youth and rejuvenation, it is difficult to solve. However, parents who aren’t old can still give birth to young children. xataca.com explains this as cell reprogramming has dominated natural life.
Amazon’s Jeff Bezos is the billionaire; technology investor Yuri Milner, his wife, made huge fortunes on Facebook.
The MIT Technology Review magazine confirmed that Steve Horvath from UCLA will join the project. He developed a molecular biomarker for aging that is now called the Horvath clock.
Shinya Yamanaka, a Kyoto University student, will join the team and will be an unpaid consultant at Altos Labs.
Yamanaka shared the 2012 Nobel Prize with Horvath for discovering four proteins called “Yamanaka factor” (four proteins). These proteins can also be added to cells to induce degeneration and achieve the desired ductility in immature cells.
Manuel Serrano of the Institute of Biomedical Research in Barcelona, Spain, took advantage of this discovery. He used the technique on whole mice rather than individual cells and got mixed results.
Serrano joined Altos Labs in order to “reprogram” cells to a younger stage. The start-up company offered Serrano a job and his salary would be five to tenfold the current salary.
Altos Labs was founded in the early 2021. It already has offices in Silicon Valley and San Diego, as well as in the United Kingdom, Japan, and is similar to Calico Labs which was started by Larry Page in 2013.
The company has raised more than $270 millions in capital. His philosophy is to pursue research under the direction of curiosity. At the beginning, his goal wasn’t to find products or generate immediate financial returns but rather to make amazing scientific discoveries.
Serrano explained that while a successful treatment may be worth billions, the Altos lab wants to “learn more about rejuvenation.” “I think there are great ideas in the future but this is not our immediate goal.”
Alejandro Ocampo, a professor at the University of Lausanne, Switzerland, believes that this concept is “solid, but the expectations are too much”, because one of the problems is that reprogramming not only makes the cells appear younger, but also this It will also change your identity.
It transforms skin cells into stem cell, making this technology very dangerous for human use. I feel that this topic is rapidly developing. I don’t know if we should have 5-8 reprogramming companies, It seems that everything is going too fast. Is there enough research on reprogramming available? Ocampo believes that the same number of companies are working on this topic.”